Market cap
$38 Mln
Revenue (TTM)
$15 Mln
P/E Ratio
--
P/B Ratio
0.7
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 18.04 | 139.59 | 55.58 | -- | -- |
| EBIT | 17.47 | -27.02 | -75.78 | -- | -- |
| Net Profit | 16.97 | -25.35 | -64.84 | -- | -- |
| EPS | -- | -- | -- | -- | -- |
| Book Value | -- | -- | -- | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-21 | Dec-20 |
| EBIT-Margin
| -- | -- | -351.97 | -365.05 | -263.31 |
| Net Margin
| -- | -- | -342.67 | -440.60 | -- |
| Return on equity
| -- | -- | -- | -119.27 | 109.28 |
| Return on Capital
| -- | -- | -- | -97.46 | 181.30 |
| Return on Assets
| -- | -- | -45.29 | -54.44 | -54.89 |
| Debt to Equity (x)
| -- | -- | -0.18 | 0.07 | -0.33 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Codex DNA Inc (DNAY)
|
--
|
-97.46
|
181.30
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
--
--
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Codex DNA Inc (DNAY)
|
--
|
-119.27
|
109.28
|
--
|
--
|
|
Peer Median
|
4.94
|
--
|
--
|
--
|
--
|
ROA
-45.29
Lower than Peers by 47.74
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Codex DNA Inc (DNAY)
|
-45.29
|
-54.44
|
-54.89
|
--
|
--
|
|
Peer Median
|
2.45
|
--
|
--
|
--
|
--
|
EBIT Margin
-351.97
Lower than Peers by 360.44
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Codex DNA Inc (DNAY)
|
-351.97
|
-365.05
|
-263.31
|
--
|
--
|
|
Peer Median
|
8.47
|
--
|
--
|
--
|
--
|
Net Margin
-342.67
Lower than Peers by 347.35
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Codex DNA Inc (DNAY)
|
-342.67
|
-440.60
|
-273.87
|
--
|
--
|
|
Peer Median
|
4.68
|
--
|
--
|
--
|
--
|
Cash Profit Margin
0.00
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Codex DNA Inc (DNAY)
|
0.00
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
55.58
Higher than Peers by 47.10
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Codex DNA Inc (DNAY)
|
55.58
|
0.68
|
--
|
--
|
--
|
|
Peer Median
|
8.49
|
--
|
--
|
--
|
--
|
EBIT Growth
-75.78
Lower than Peers by 86.43
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Codex DNA Inc (DNAY)
|
-75.78
|
-132.82
|
-106.84
|
--
|
--
|
|
Peer Median
|
10.65
|
--
|
--
|
--
|
--
|
Net Profit Growth
-64.84
Lower than Peers by 78.39
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Codex DNA Inc (DNAY)
|
-64.84
|
-116.31
|
--
|
--
|
--
|
|
Peer Median
|
13.55
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
-0.18
Lower than Peers by 0.58
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Codex DNA Inc (DNAY)
|
-0.18
|
0.07
|
-0.33
|
-0.64
|
--
|
|
Peer Median
|
0.40
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
-0.01
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Codex DNA Inc (DNAY)
|
-0.01
|
0.02
|
-0.08
|
-0.01
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
4.86
Higher than Peers by 2.03
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Codex DNA Inc (DNAY)
|
4.86
|
9.57
|
3.05
|
18.25
|
--
|
|
Peer Median
|
2.83
|
--
|
--
|
--
|
--
|
Quick Ratio
4.68
Higher than Peers by 2.64
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Codex DNA Inc (DNAY)
|
4.68
|
9.33
|
2.95
|
17.84
|
--
|
|
Peer Median
|
2.05
|
--
|
--
|
--
|
--
|
Interest Coverage
-14.89
Lower than Peers by 19.85
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Codex DNA Inc (DNAY)
|
-14.89
|
-29.45
|
-25.09
|
--
|
--
|
|
Peer Median
|
4.96
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
36.75
Higher than Peers by 20.29
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Codex DNA Inc (DNAY)
|
36.75
|
33.19
|
22.69
|
--
|
--
|
|
Peer Median
|
16.46
|
--
|
--
|
--
|
--
|
Asset Turnover
0.13
Lower than Peers by 0.37
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Codex DNA Inc (DNAY)
|
0.13
|
0.15
|
0.20
|
--
|
--
|
|
Peer Median
|
0.50
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Codex DNA Inc (DNAY)
|
--
|
85.28
|
82.87
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Codex DNA Inc (DNAY)
|
--
|
80.40
|
81.26
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Codex DNA Inc (DNAY)
|
--
|
99.92
|
111.70
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Codex DNA Inc (DNAY)
|
--
|
65.76
|
52.42
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Book Value
0.65
Lower than Peers by 3.18
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Codex DNA Inc (DNAY)
|
0.65
|
--
|
--
|
--
|
--
|
|
Peer Median
|
3.84
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Codex DNA Inc (DNAY)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
-0.13
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Codex DNA Inc (DNAY)
|
-0.13
|
1.94
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
38
Lower than Peers by 504
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Codex DNA Inc (DNAY)
|
38
|
--
|
--
|
--
|
--
|
|
Peer Median
|
542
|
--
|
--
|
--
|
--
|